2014 Capital Incubator Seed Funding 
socalTECH
OCTOBER 11, 2018
This morning, Moonshots Capital (www.moonshotscapital.com), led by Kelly Perdew and Craig Cummings , announced its first formal fund, a $19M seed stage fund. We had been doing that for several years, and decided we wanted to start syndicating deals in September of 2014, so we formed Moonshots Capital.
Both Sides of the Table
DECEMBER 14, 2014
I had witnessed a number of early-stage tech startups in LA raise seed capital from the Bay Area and relocate. and I thought if we brought the community together for common purpose we could create more of a sense of community to help new entrepreneurs get funded, assemble teams, raise profiles and help with biz dev, product, etc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch LA
NOVEMBER 4, 2019
Bain Capital Ventures' Jamison Hill. We are in phase three of the influencer economy,” Bain Capital Ventures senior principal Jamison Hill, who led the firm’s investment in the influencer shoutout marketplace Cameo , tells TechCrunch. Naturally, these were also the first business to get funded.
InfoChachkie
APRIL 14, 2014
ABC has even created an incubator-style program in which startup non-profits compete for $100,000 in seed funding. In many ways, you act as a venture capital firm, with returns measured in impact, rather than profits. What are the key factors you look when assessing to fund a non-profit? JG: I love it!
Startup Professionals Musings
OCTOBER 12, 2014
Join a startup incubator or accelerator. Most provide free resources to startups, including office facilities and consulting, but many provide seed funding as well. Solicit venture capital investors. Solicit venture capital investors. Marty Zwilling First published on Entrepreneur.com on 10/03/2014.
Xconomy
JUNE 3, 2016
Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). —When Merck (NYSE: MRK ) bought Cubist Pharmaceuticals for $9.5
Expert insights. Personalized for you.
164 
Let's personalize your content